| Implementation of buffy coat platelet component production: comparison to platelet‐rich plasma platelet production E Levin, B Culibrk, MIC Gyöngyössy‐Issa, S Weiss, K Scammell, ... Transfusion 48 (11), 2331-2337, 2008 | 101 | 2008 |
| Canadian experience with detection of bacterial contamination in apheresis platelets S Ramírez‐Arcos, C Jenkins, J Dion, F Bernier, G Delage, M Goldman Transfusion 47 (3), 421-429, 2007 | 100 | 2007 |
| Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk C Jenkins, S Ramírez‐Arcos, M Goldman, DV Devine Transfusion 51 (12), 2555-2565, 2011 | 77 | 2011 |
| A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing JP Acker, AL Hansen, JDR Kurach, TR Turner, I Croteau, C Jenkins Transfusion 54 (10), 2534-2543, 2014 | 76 | 2014 |
| The effect of processing method on the in vitro characteristics of red blood cell products AL Hansen, JDR Kurach, TR Turner, C Jenkins, MP Busch, PJ Norris, ... Vox sanguinis 108 (4), 350-358, 2015 | 60 | 2015 |
| Changes in coagulation factor activity and content of di (2‐ethylhexyl) phthalate in frozen plasma units during refrigerated storage for up to five days after thawing WP Sheffield, V Bhakta, C Mastronardi, S Ramirez‐Arcos, D Howe, ... Transfusion 52 (3), 493-502, 2012 | 29 | 2012 |
| Conversion to the buffy coat method and quality of frozen plasma derived from whole blood donations in Canada WP Sheffield, V Bhakta, C Jenkins, DV Devine Transfusion 50 (5), 1043-1049, 2010 | 25 | 2010 |
| Segments from red blood cell units should not be used for quality testing JDR Kurach, AL Hansen, TR Turner, C Jenkins, JP Acker Transfusion 54 (2), 451-455, 2014 | 20 | 2014 |
| Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services E Levin, C Jenkins, B Culibrk, MIC Gyöngyössy‐Issa, K Serrano, ... Transfusion, 2012 | 18 | 2012 |
| Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20–24 C for up to 24 h WP Sheffield, V Bhakta, C Jenkins Vox sanguinis 110 (1), 12-19, 2016 | 15 | 2016 |
| Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw V Bhakta, C Jenkins, S Ramirez‐Arcos, WP Sheffield Transfusion 54 (2), 418-425, 2014 | 15 | 2014 |
| Bacterial survival and distribution during buffy coat platelet production M Taha, M Kalab, QL Yi, E Maurer, C Jenkins, P Schubert, ... Vox sanguinis 111 (4), 333-340, 2016 | 13 | 2016 |
| Stability of thawed apheresis fresh-frozen plasma stored for up to 120 hours at 1 C to 6 C WP Sheffield, V Bhakta, QL Yi, C Jenkins Journal of blood transfusion 2016, 2016 | 12 | 2016 |
| Quality of frozen transfusable plasma prepared from whole blood donations in Canada: an update WP Sheffield, V Bhakta, K Talbot, ELG Pryzdial, C Jenkins Transfusion and Apheresis Science 49 (3), 440-446, 2013 | 10 | 2013 |
| Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method C Mastronardi, P Schubert, E Levin, V Bhakta, QL Yi, A Hansen, T Stewart, ... Journal of blood transfusion 2013, 2013 | 7 | 2013 |
| Bacteria can proliferate in thawed cryoprecipitate stored at room temperature for longer than 4 h S Ramirez‐Arcos, C Jenkins, WP Sheffield Vox sanguinis 112 (5), 477-479, 2017 | 6 | 2017 |
| Relative safety of buffy coat platelet pools D Devine, C Jenkins, D Howe, M Goldman Transfusion 7 (50), 1591-1592, 2010 | 6 | 2010 |
| Sporadic formation of cryoprecipitate‐like particulate matter in thawed fresh‐frozen plasma units WP Sheffield, V Bhakta, M Rogerson, C Jenkins Transfusion 50 (4), 949-950, 2010 | 3 | 2010 |
| INSIGHTS INTO BACTERIAL SURVIVAL AND DISTRIBUTION DURING BUFFY COAT PLATELET PRODUCTION: P-422 S Ramirez-Arcos, M Taha, P Schubert, E Maurer, C Jenkins Vox Sanguinis 109, 2015 | 1 | 2015 |
| Transport Conditions of Whole Blood Prior To Leukoreduction and Processing Impacts Quality of RBC Products: SP57 A Hansen, T Turner, J Tchir, W Lefresne, C Jenkins, J Acker Transfusion 52, 2012 | 1 | 2012 |
